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Cranial neural crest cells (CNCCs), identified by expression of transcription factor Sox9,
migrate to the first branchial arch and undergo proliferation and differentiation to form
the cartilage and bone structures of the orofacial region, including the palatal bone.
Sox9 promotes osteogenic differentiation and stimulates CXCL12-CXCR4 chemokine-
receptor signaling, which elevates alkaline phosphatase (ALP)-activity in osteoblasts
to initiate bone mineralization. Disintegration of the midline epithelial seam (MES) is
crucial for palatal fusion. Since we earlier demonstrated chemokine-receptor mediated
signaling by the MES, we hypothesized that chemokine CXCL12 is expressed by the
disintegrating MES to promote the formation of an osteogenic center by CXCR4-positive
osteoblasts. Disturbed migration of CNCCs by excess oxidative and inflammatory stress
is associated with increased risk of cleft lip and palate (CLP). The cytoprotective heme
oxygenase (HO) enzymes are powerful guardians harnessing injurious oxidative and
inflammatory stressors and enhances osteogenic ALP-activity. By contrast, abrogation
of HO-1 or HO-2 expression promotes pregnancy pathologies. We postulate that Sox9,
CXCR4, and HO-1 are expressed in the ALP-activity positive osteogenic regions within
the CNCCs-derived palatal mesenchyme. To investigate these hypotheses, we studied
expression of Sox9, CXCL12, CXCR4, and HO-1 in relation to palatal osteogenesis
between E15 and E16 using (immuno)histochemical staining of coronal palatal sections
in wild-type (wt) mice. In addition, the effects of abrogated HO-2 expression in HO-2
KO mice and inhibited HO-1 and HO-2 activity by administrating HO-enzyme activity
inhibitor SnMP at E11 in wt mice were investigated at E15 or E16 following palatal fusion.
Overexpression of Sox9, CXCL12, CXCR4, and HO-1 was detected in the ALP-activity
positive osteogenic regions within the palatal mesenchyme. Overexpression of Sox9
and CXCL12 by the disintegrating MES was detected. Neither palatal fusion nor MES
disintegration seemed affected by either HO-2 abrogation or inhibition of HO-activity.
Sox9 progenitors seem important to maintain the CXCR4-positive osteoblast pool to
drive osteogenesis. Sox9 expression may facilitate MES disintegration and palatal fusion
by promoting epithelial-to-mesenchymal transformation (EMT). CXCL12 expression by
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the MES and the palatal mesenchyme may promote osteogenic differentiation to create
osteogenic centers. This study provides novel evidence that CXCL12-CXCR4 interplay
facilitates palatal osteogenesis and palatal fusion in mice.
Keywords: embryology, cranial neural crest cells, Sox9, osteogenesis, palatogenesis, CXCL12-CXCR4,
pathological pregnancy, heme oxygenase
INTRODUCTION
In the process of craniofacial development, cranial neural crest
cells (CNCCs) migrate from the lateral ridges of the neural plate
to the first branchial arch to form the orofacial region, including
the maxilla, mandible, zygoma, trigeminal nerve, and muscles
of mastication (Ito et al., 2003; Lee and Saint-Jeannet, 2011;
Birgfeld and Heike, 2019). CNCCs have to migrate and undergo
proliferation and differentiation to form the dentin and pulp
of the teeth, connective tissues, cartilage, and bone of the head
(Chai et al., 2000; Sakai and Trainor, 2009; Achilleos and Trainor,
2012). In animal studies, CNCCs populating the pharyngeal
arches are characterized by expression of transcription factor
Sox9 (Li et al., 2002; Cheung and Briscoe, 2003; Hong and
Saint-Jeannet, 2005; Lee and Saint-Jeannet, 2011; Wu et al.,
2017). In addition, Sox9 acts as a key transcription factor that is
required for both early and late stages of osteogenic (Yamashiro
et al., 2004; Stockl et al., 2013; Loebel et al., 2015; Rutkovskiy
et al., 2016) and chondrogenic differentiation (Akiyama et al.,
2002, 2005; Hattori et al., 2010; Guang et al., 2012; Henry
et al., 2012; Jeon et al., 2014; Rutkovskiy et al., 2016). To
initiate bone formation, CNCCs were found to form aggregated
cell masses in the orofacial mesenchyme (Ito et al., 2003).
In mice fetuses, Sox9 expression has been observed in the
osteogenic cell compartments in the craniofacial bones between
E12-E16 (Yamashiro et al., 2004). CXCL12-CXCR4 chemokine-
receptor signaling drives both osteogenic and chondrogenic
differentiation (Ito, 2011). CXCL12-CXCR4 signaling mediates
both immature and mature murine osteoblast development (Zhu
et al., 2011; Shahnazari et al., 2013). Moreover, CXCL12-CXCR4
signaling promotes Sox9-mediated chondrogenesis in synovium-
derived stem cells (Wang et al., 2017), whilst blocking CXCL12-
CXCR4 signaling inhibits chondrogenic differentiation in vitro
(Guang et al., 2012). However, Sox9 knockout (KO) mice show
reduced CXCR4 expression in the kidney (Reginensi et al., 2011).
CXCL12-CXCR4 signaling regulates osteoblast formation
by promoting alkaline phosphatase (ALP)-activity in human
(Hosogane et al., 2010; Li et al., 2017), and murine osteoblasts
(Liu et al., 2013) in vitro. ALP-activity is often used as a
marker of osteoblastic development (Stein and Lian, 1993),
and ALP KO mice demonstrate defects in bone mineralization
(Wennberg et al., 2000). Mesenchymal stem cells exposed
to osteogenic medium with CXCL12 demonstrated higher
ALP-activity, supporting a role for CXCL12 in osteogenic
differentiation in vitro (Kortesidis et al., 2005).
Since Sox9 expression was observed in the palatal shelves
in mice fetuses at E12.5, E13.5 (Watanabe et al., 2016), E14.5
(Potter and Potter, 2015; Watanabe et al., 2016), and E15 (Xu
et al., 2018), migrating CNCCs are thought to contribute to
the embryonic formation of the palate, named palatogenesis
(Watanabe et al., 2016; Xu et al., 2018). Palatogenesis is an
important event during craniofacial development of higher
vertebrates (Ferguson, 1988). Our basic understanding of palatal
morphogenesis comes principally from research conducted
in mice. Palatogenesis occurs during the intrauterine weeks
8–12 in humans and during embryonic days E12–E15.5 in
mice (Dudas et al., 2007). Palatogenesis involves the vertically
downward outgrowth of the paired palatal shelves from the
maxillary region, elevation above the tongue (E14.5-E15),
horizontal growth and adherence, formation of the midline
epithelial seam (MES), and eventually disintegration of the MES,
allowing complete palatal fusion (E15.5) (Chai and Maxson,
2006; Dudas et al., 2007; Levi et al., 2011). Cranial neural
crest-derived mesenchymal cells have to undergo osteogenic
differentiation to form the hard palate (Xu et al., 2019). In
mice, CNCCs form aggregated cell masses to initiate palatal
bone formation in the palatal mesenchyme in mice between
E14.5 and E16.5 (Ito et al., 2003; Oka et al., 2012). In cultured
mouse palatal shelves, inhibition of osteoblast differentiation by
treatment with 10 mM lithium chloride prevented palatal fusion
(Meng et al., 2015).
Since CXCL12-CXCR4 expression was found to promote
bone formation (Zhu et al., 2011; Shahnazari et al., 2013)
and ALP-activity (Kortesidis et al., 2005), we postulate that
both CXCL12 and CXCR4 are expressed within the palatal
mesenchyme to facilitate palatal osteogenesis. Transcription
factor Sox9 may promote CXCL12-CXCR4 signaling to initiate
ALP-activity, facilitating osteoblast and chondrocyte formation
within the CNCCs derived mesenchyme, starting osteogenesis in
the developing orofacial region.
Midline epithelial seam disintegration is crucial for palatal
fusion (Iseki, 2011). The main hypotheses underlying MES
disintegration during palatal fusion involve epithelial cell
migration to the oral (Aoyama et al., 2019; Logan and
Benson, 2019) or nasal epithelium (Jin and Ding, 2006;
Aoyama et al., 2019), epithelial-to-mesenchymal transformation
(EMT) (Nawshad, 2008; Serrano et al., 2015; Nakajima et al.,
2018), epithelial cell apoptosis (Lan et al., 2015; Suttorp
et al., 2017), or a combination of these events (Iseki, 2011).
We previously demonstrated that the MES highly expresses
chemokine CXCL11, suggesting its involvement in recruiting
CXCR3-positive macrophages to facilitate phagocytosis of
apoptotic cells of the disintegrating MES during palatal fusion
(Suttorp et al., 2017). Notably, palatal bone formation in mice
starts at E14.5 (Ito et al., 2003; Oka et al., 2012), simultaneously
with MES disintegration (Chai and Maxson, 2006; Dudas et al.,
2007; Levi et al., 2011). Therefore, we postulate that the MES
might also express other chemokines involved in other pathways,
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such as CXCL12, to promote maturation of immature CXCR4-
positive osteoblasts and ALP-activity to start palatal osteogenesis.
Disturbed migration of CNCCs to the orofacial region
can lead to craniofacial abnormalities (Wang et al., 2019).
Exposure to reactive oxygen species (ROS), generated by diabetes,
infections, or social poisons, including maternal smoking,
alcohol consumption, and exposure to teratogens, was found
to harm fetal growth and development and could even lead
to craniofacial anomalies in rats (Al Ghafli et al., 2004),
zebrafish (Kim et al., 2014; de Peralta et al., 2016), and humans
(Simpson, 1957; Andres, 1996; Shah and Bracken, 2000; Ion
and Bernal, 2015; Parks, 2015; Zadzinska et al., 2016). ROS
can contribute to the etiology of congenital malformations by
disrupting migration of CNCCs to the orofacial region (Sakai
and Trainor, 2016). In chick embryo, ROS production generated
by caffeine exposure was found to disturb CNCC migration,
leading to asymmetrical microphthalmia and abnormal orbital
bone development (Ma et al., 2014).
During palatogenesis, failure of elevation, horizontal growth,
adherence of the palatal shelves, or disruption of MES formation
and MES disintegration results in cleft palate (Nakajima et al.,
2018). Palatal clefting can be caused by disturbed migration of
CNCCs to the orofacial region (Wang et al., 2019). In humans,
disruption of CNCC migration to the oral region can lead to cleft
lip and palate (CLP) (Ito et al., 2003) and Pierre Robin sequence,
a congenital craniofacial anomaly characterized by mandibular
micrognathia, glossoptosis, and cleft palate (Jakobsen et al., 2006;
Chen et al., 2019).
A combination of genetic and environmental factors is
thought to play a role in the etiology of orofacial clefting
(Spilson et al., 2001; Mossey et al., 2009; Brocardo et al., 2011).
Mice lacking transcription factor AP-2a show hampered CNCC
migration resulting in congenital anomalies, including cleft
palate (Nottoli et al., 1998). Repression of CNCC proliferation
by inhibiting the transcription factor family Zeb prevents
fusion between cultured mice palatal shelves in vitro (Shin
et al., 2018). Failure of palatal bone formation between
E14.5 and E16.5 in mice is associated with cleft palate (Oka
et al., 2012). Maternal smoking (Shi et al., 2008), alcohol
consumption (DeRoo et al., 2008), and diabetes (Correa
et al., 2008), associated with oxidative and inflammatory
stress (Chen and Scholl, 2005; Albano, 2006; Kamceva et al.,
2016), were found to increase the risk at babies with
CLP. Gestational treatment with nicotine inhibited palatal
fusion by persistence of the MES in mice fetuses (Kang
and Svoboda, 2003; Ozturk et al., 2016). In pregnant CL/Fr
mice, having an incidence of spontaneous CLP of 35–40%
in the offspring, exposure to hypoxia at E11 doubled the
incidence of CLP at E18, indicating that a combination
of genetic susceptibility and oxidative stress can result in
CLP(Millicovsky and Johnston, 1981).
The heme oxygenase (HO) enzyme system protects against
oxidative and inflammatory stress by degrading the pro-
oxidant heme, thereby generating free iron/ferritin, carbon
monoxide (CO), and the antioxidants biliverdin/bilirubin
(Wagener et al., 2003; Grochot-Przeczek et al., 2012; Gorlach
et al., 2015). These HO-effector molecules regulate vasodilation,
inhibit platelet aggregation, suppress leukocyte adhesion, and
reduce pro-inflammatory cytokine release (Grochot-Przeczek
et al., 2012). The HO-system consists of two functional
isoforms; HO-1 has low basal levels but is strongly inducible,
whereas HO-2 is constitutively expressed (Ewing and Maines,
2006). Downregulation of HO-1 (Zenclussen et al., 2003)
and HO-2 (Sollwedel et al., 2005) in human placenta is
associated with spontaneous abortion, pre-eclampsia, and
fetal growth retardation. HO-2 KO mice demonstrated fetal
growth restriction, severe malformations, craniofacial anomalies
(Suttorp et al., 2017), and elevated endothelial inflammatory
and angiogenic factors (Bellner et al., 2009). HO-1 KO mice
demonstrated a high prenatal mortality, with survivors showing
growth retardation, organ fibrosis, and inflammatory tissue
damage (Kapturczak et al., 2004). Others found that HO-1 KO
mice are highly susceptible to ischemia, reperfusion injury, and
right ventricular infarction (Yoshida et al., 2001; Liu et al., 2005).
Induction of HO-1 decreased ROS levels in obese diabetic mice
(Li et al., 2008). Interestingly, HO-1 expression promoted ALP-
activity in the process of differentiation of osteoblast stem cells
of human (Barbagallo et al., 2010; Vanella et al., 2012; Kim et al.,
2013; Guo et al., 2017), mouse (Cheng et al., 2019), and rat into
osteoblasts (Gu et al., 2012). In human periodontal ligament
cells, induction of HO-1 leads to upregulation of osteogenic
differentiation in vitro (Kook et al., 2009). However, blocking
of HO-activity has therapeutically been used in preterm infants
since administration of SnMP, a competitive inhibitor of HO-1
and HO-2, attenuates the development of hyperbilirubinemia
(Valaes et al., 1994).
We postulate that Sox9, CXCR4, and HO-1 are expressed
in the ALP-activity positive osteogenic regions within the
CNCCs derived mesenchyme during palatal fusion in mice.
Furthermore, we hypothesize that chemokine CXCL12 is
expressed by the disintegrating MES to promote the formation
of an osteogenic center by CXCR4-positive osteoblasts. In
addition, we expect that increased levels of oxidative and
inflammatory stress in HO-2 KO mice, and further increase
of these stress levels, obtained by administration of HO-1 and
HO-2 activity inhibitor SnMP at E11 in wt mice disrupts the
migration of CNCCs to the orofacial region, increasing the risk
of cleft palate.
In the present study, expression of Sox9, CXCL12, CXCR4,
and HO-1 was studied in relation to MES disintegration at E15
and palatal osteogenesis between E15 and E16 marked by ALP-
activity, in wild-type (wt) mice using (immuno)histochemical
staining of coronal palatal sections. Additionally, the effects of
absence of HO-2 in HO-2 KO mice, or inhibition of HO-1 and
HO-2 activity using SnMP from E11 in wt mice on palatal bone
formation at E15 and E16, was investigated.
MATERIALS AND METHODS
Mice Selection and Mating
Because HO-1 KO mice demonstrated severe pregnancy
complications with a fetal loss rate of more than 85% (Zenclussen
et al., 2011), and HO-2 mice demonstrated to be viable
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FIGURE 1 | Isolation of the uteri and mice fetuses. After sacrifice of the plugged mice the uteri were isolated: (A) wt E15 mouse. (B) wt E15 mouse, (C) wt CD1
SnMP E16 mouse, (D,E) HO-2 KO E15 mouse. (F) Isolation of the fetuses from the uterus of a HO-2 KO E15 mouse. Left panel: Uterus containing 6 fetuses (green
asterisks) in total. Middle panel: After removal of the fetuses five resorptions (red asterisks) were found (centimeter ruler). Right panel: Overview of the six isolated
fetuses with placenta (green asterisks).
(Lundvig et al., 2014), the HO-2 mouse model was considered
more suitable to collect fetuses for this study. Homozygote
HO-2 KO mice were generated by targeted disruption of
the HO-2 gene with mixed 129Sv × C57BL/6 background
(Poss et al., 1995; Bellner et al., 2009). By quantitative real-
time PCR, we previously confirmed the genotypes of mice
by showing that HO-2 mRNA was only present in samples
from wt fetuses, and not in HO-2 KO fetuses (Suttorp et al.,
2017). The wt mice strain with mixed 129Sv × C57BL/6
background were used to obtain fetuses for the control
group. Both the wt (n = 7) and HO-2 KO mice (n = 7)
of 8 weeks old were bred and maintained in our animal
facility. Female wt mice were mated with wt males, and
female HO-2 KO mice were mated with HO-2 KO males.
The next morning the mice were checked for the presence
of a vaginal copulation plug, taken as day 0 of pregnancy
(gestational/embryonic day 0; E0) (Behringer et al., 2016).
Preliminary experiments (Ethical permission # RU-DEC 2009-
160) demonstrated that both wt and HO-2 KO animals with
mixed 129Sv × C57BL/6 background often did not carry fetuses.
The hormones Folligonan (Gonadotropin serum, Intervet
Nederland BV, Boxmeer, Netherlands) and Pregnyl (Human
chorionic gonadotropin, NV Organon, Oss, Netherlands)
were used to enhance the chance of pregnancy. At day –3
at 16.00 h Folligonan (6E in 30 µl) and at day –1 at 16.00 h
Pregnyl (6E in 30 µl) was administered by intraperitoneal
(i.p.) injection. At first, 1 wt mouse and two HO-2 KO mice
demonstrated no plugged status. These animals were mated
again 4 weeks later, and all demonstrated a plugged status
the next morning.
Female CD1 mice of 12–17 weeks old (n = 11) were mated
with male mice from the same strain at the animal facility
of the animal suppliers Envigo (Venray, Netherlands). The
plugged CD1 mice were transported to our animal facility
and could acclimatize for at least 1 week before the start
of the experiment. Absence of HO expression (both isoforms
HO-1 and HO-2) was found to severely affect embryonic
implantation (Zenclussen et al., 2011). SnMP can bind to the
enzymes HO-1 and HO-2, but cannot be broken down by both
isotypes, acting as a competitive inhibitor of the HO system
(Stevenson et al., 1989). Instead of heme (iron protoporphyrin
IX dichloride), SnMP (Sn mesoporphyrin IX dichloride) consists
of a protoporphyrin IX ring with tin in its center (Lutton
et al., 1999). SnMP was purchased from Frontier Scientific
(Carnforth, United Kingdom). SnMP was freshly dissolved with
Trizma base. The pH was adjusted to pH 7.6–8.0 with HCl,
and further diluted till 10 mL with H2O. The SnMP solution
was filter sterilized before administration. To be able to study
palatal fusion in the absence of HO-1 and HO-2 activity (later
referred to as HO-activity), pharmacological blocking in CD1
wt mice was obtained by administration of SnMP at the start of
palatogenesis at E11.
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Sample Size, Housing, Ethical
Permission
To detect an effect size of 0.40 (generalized estimation of the
reduction in fetal body weight following HO-2 abrogation/HO-
activity inhibition) with power of 0.80 and a significance level of
0.05 for the four groups (wt E15, HO-2 KO E15, wt CD1 E16,
and wt CD1 SnMP E16) a total sample size of n = 76 fetuses
for this study was calculated by the one-way ANOVA power
analysis a priori (G∗Power 3.1 software) (Faul et al., 2007). This
indicated that the mean sample size per group should comprise
approximately 19 fetuses. We estimated that the litter size could
range from 8 to 18 fetuses, suggesting that each group should
contain three pregnant mice. The chance of conception was
assumed to be around 70%, indicating that for each group at least
five mice should be mated.
The animals of both models were housed under specific
pathogen-free housing conditions with 12 h light/dark cycle and
ad libitum access to water and powdered rodent chow.
Ethical permission for the study was obtained according to the
guidelines of the Board for Animal Experiments of the Radboud
University Nijmegen (Ethical permission # RU-DEC 2012-166).
Studying Chemokine Expression by the
MES in the Presence or Absence of HO-2
To be able to study chemokine expression by the MES, fetuses
should be studied before the palatal shelves are completely fused.
In wt mice the palatal shelves fuse between E14.5 and E15.5.
In this period, the MES disintegrates, allowing the formation
of mesenchymal confluence (Dudas et al., 2007). Therefore,
fetuses of E15 were considered to be suitable to study chemokine
expression by the disintegrating MES. In the absence of HO-2
expression chemokine expression by the MES was examined in
HO-2 KO fetuses of E15 (later referred to as HO-2 KO E15). The
E15 wt fetuses served as controls (later referred to as wt E15).
Studying Palatal Fusion in the Presence
or Absence of HO-Activity
To be able to study palatal clefting, fetuses should be studied
beyond the time point of palatal fusion. Since the epithelium of
the palatal shelves loses its capacity to fuse at E16, the absence of
palatal fusion at E16 is diagnosed as palatal clefting (Dudas et al.,
2007). Therefore, fetuses of E16 were considered to be suitable
to study palatal fusion. In the absence of HO-activity, obtained
by SnMP administration, palatal fusion was examined in wt CD1
fetuses of E16 (later referred to as wt CD1 SnMP E16). In the
control group, no SnMP was administered (later referred to as wt
CD1 E16). All CD1 mice were randomly assigned to the wt CD1
E16 or wt CD1 SnMP E16 group.
Isolation of Mice Fetuses
The plugged animals of both models were sacrificed by CO2/O2
inhalation for 10 min, and the uteri and fetuses were isolated and
photographed (see Figure 1). The wt and HO-2 KO mice were
sacrificed at E15. Only three out of seven plugged wt mice, and
four out of seven plugged HO-2 KO mice carried fetuses. In total,
16 wt E15 fetuses and 11 HO-2 KO E15 fetuses were obtained.
The CD1 wt mice, the controls, and SnMP administered mice,
were sacrificed at E16. In total of six out of six plugged wt mice
of the control group, and four out of five plugged wt mice of the
SnMP group carried fetuses. In total, 91 wt CD1 E16 fetuses and
56 wt CD1 SnMP E16 fetuses were obtained.
Fetal Loss Rate Calculation
For the fetus-carrying mice of both models, the fetal loss rate,
the percentage of non-viable and hemorrhagic embryonic
implantations to the total number of embryonic implantations
(non-viable or hemorrhagic embryonic implantations +
fetuses) was calculated.
Fetal Body Weight
To study the effects of the absence of HO-2 expression on fetal
growth wt E15 fetuses (n = 15) and HO-2 KO E15 fetuses (n = 4)
were weighed. Unfortunately, when the isolation of the uterus
was performed for the first time, we weighed the fetuses in their
amniotic sacs together with their placentas. During preparation
we noticed that in some cases the amniotic fluid was partially
leaked away caused by a perforation of the amniotic membrane,
making this method unreliable. Subsequently, it was decided
to perform the weighing of the fetuses separately from their
amniotic sacs and placentas. Therefore, the weight of 1 wt E15
and 7 HO-2 KO E15 fetuses was not collected. To study the effects
of HO-activity inhibition on fetal growth the wt CD1 E16 fetuses
(n = 91) and wt CD1 SnMP E16 fetuses (n = 56) were weighed.
Paraffin Embedding and Section Cutting
of Head Samples
Fetuses were decapitated and the head samples were fixed
for 24 h in 4% paraformaldehyde and further processed
for routine paraffin embedding. Serial coronal sections
through the secondary palate region of 5-µm thickness
were mounted on Superfrost Plus slides (Menzel-Gläser,
Braunschweig, Germany). The paraffin sections were
deparaffinized using Histosafe (Adamas Instrumenten
B.V., Rhenen, Netherlands) and rehydrated using an
alcohol range (100%–90%–80%–70%–35%–0%) for further
(immuno)histochemistry.
Palatogenesis Classification of
HE-Stained Palatal Sections
Serial coronal palatal sections from the wt E15, HO-2 KO E15, wt
CD1 E16 and wt CD1 SnMP E16 fetuses were routinely stained
with hematoxylin and eosin (HE). Because the palate is not fused
in once, the four stages according to Dudas et al. (2007) and
Suttorp et al. (2017) can all be present on the same embryonic
day. Therefore, the sections were classified into the four stages
of palatogenesis based on the anatomy of the secondary palatal
shelves: elevation, horizontal growth, midline adhesion, and
fusion. Per individual fetus palatogenesis was studied on multiple
sections. A minimum of five sections from five to seven head
samples per group were essayed. Microscopic photographs
were taken using a Carl Zeiss Imager Z.1 system (Carl Zeiss
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TABLE 1 | First and secondary antibodies used for CXCL12, Sox9, CXCR4, and HO-1 immunohistochemical staining.
First antibody Specificity Concentration
(µg/ml)
Source
14-7992-81 CXCL12 10 Affymetrix eBioscience, San Diego, CA, United States
Sc 17340 Sox9 0,33 Santa Cruz via Bio-Connect, Santa Cruz, CA, United States
PA3-305 CXCR4 3,33 Thermo Fisher Scientific, Waltham, MA, United States
SPA 895 HO-1 2 Enzo Life Sciences BVBA, Bruxelles, Belgium
Secondary antibody Specificity Concentration
(µg/ml)
Color Source
101909 Donkey anti Rabbit
Biotine
3,4 – Jackson Immunoresearch Europe LTD, Ely, United Kingdom
714270 Donkey anti Goat Alexa
Fluor 594
20 Red Invitrogen Thermo Fisher Scientific, Waltham, MA,
United States
A11008 Goat anti Rabbit Alexa
Fluor 488
4 Green Invitrogen Thermo Fisher Scientific, Waltham, MA,
United States
1777945 Goat anti Rabbit Alexa
Fluor 594
4 Red Invitrogen Thermo Fisher Scientific, Waltham, MA,
United States
FIGURE 2 | Palatal epithelium classification. (A) Coronal palatal section, e.g., HO-2 KO E15. (B) For each section the palatal epithelial layers were subdivided into
three regions of interest according to morphological characteristics: (Inside) epithelium of the palatal shelves from the edge, including the MES, to half of the width of
the shelves (in red); (Outside) epithelium of the lateral half of the palatal shelves (in blue); (Lateral nasal wall) epithelium of the lateral wall of the nasal cavity, this region
is positioned outside the palatal shelves and served as a control region (in yellow). Immunoreactivity scoring scale: Semi-quantitative scoring of CXCL12
immunoreactivity within the epithelial regions according to the following scale: HIGH, immunoreactivity present in almost the entire epithelial region; MODERATE,
immunoreactivity present only partially in the epithelial region; LOW, almost no immunoreactivity present in the epithelial region. Immunoreactivity scored for the three
regions of interest in a CXCL12 immunostained section. (C) Inside region was scored as HIGH, in red. (D) Outside region was scored as MODERATE, in blue. Lateral
nasal wall region was scored as LOW, in yellow.
Microimaging Gmbh, Jena, Germany) with AxioVision (4.8 v)
software (Zeiss, Göttingen, Germany). HE series from the wt E15
and HO-2 KO fetuses were used as reference to obtain coronal
palatal sections containing the MES for (immuno)histochemical
staining. HE series from the wt CD1 E16 and wt CD1 SnMP E16
fetuses were used as reference to obtain coronal palatal sections
containing the middle region of the fusing palatal shelves for
(immuno)histochemistry.
Palatal Osteogenesis Identification by
ALP-Activity
ALP-activity is often used as a marker of osteoblastic
development (Stein and Lian, 1993). In the coronal palatal
sections, increased expression of ALP activity was found to
indicate enhanced differentiation of mesenchymal stem cells into
osteoblasts (Rosa et al., 2003; George et al., 2006). Therefore,
in this study ALP-positive stained regions were judged sites of
Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 August 2020 | Volume 8 | Article 771
fcell-08-00771 August 19, 2020 Time: 20:17 # 7
Verheijen et al. CXCL12-CXCR4 Interplay Facilitates Palatal Osteogenesis
FIGURE 3 | Palatal shelf cross-sectional surface measurement determining the number of CXCL12-positive immunostained cells/mm2 within the mesenchyme.
(A) The individual cross-sectional surface of the inner half (in green) and outer half (in orange) of each palatal shelf was measured. (B) A square scale bar was drawn
in the microscopic picture of 1,000×1,000 µm (mm2) and the total number of pixels was determined (e.g., HO-2 KO E15: 1 mm2 = 635,000 pixels), data not shown.
The contour of the mesenchyme was drawn (yellow line). The number of pixels for this area was determines by the Fiji Image J 1.51n software (10,424 pixels). The
number of CXCL12-positive stained cells within this mesenchymal area of the palatal shelves was counted (e.g., inner half contains 31 CXCL12-positive cells. The
number of cells/mm2 was calculated (635,000/10,424 × 31 = 1888 cells/mm2).
initiated osteogenic differentiation. Paraffin embedded sections
were selected from the wt E15, HO-2 KO E15, wt CD1 E16,
and wt CD1 SnMP E16 fetuses. The sections were rinsed in
demineralized water. Then, the sections were incubated for
60 min with TRIS buffer at 37◦C, followed by incubation
with Medium Alkaline Phosphatase at 37◦C for half an hour.
After rinsing with demineralized water, the sections were
counterstained by Na-acetate buffer 0.1M pH 5.1, continued
with 0.1% Methyl green in Na-acetate buffer with pH 5.1.
The sections were briefly rinsed before mounting in Kaisers
gelatin. Microscopic photographs of the ALP-stained palatal
sections were taken.
Immunofluorescence Staining for Sox9,
CXCR4, and HO-1-Expression in the
Palate
For the Sox9 immunofluorescence staining, paraffin-embedded
coronal palatal sections from the wt E15 and HO-2 KO E15
fetuses containing a complete or partial MES were selected. For
the CXCR4 and HO-1, and the double-staining Sox9-CXCR4
and Sox9-HO-1 paraffin embedded sections from the wt E15,
HO-2 KO E15, wt CD1 E16, and wt CD1 SnMP E16 fetuses were
selected. Antigens were retrieved with citrate buffer at 70◦C for
10 min, following by incubation in 0.015% trypsin in PBS at 35◦C
for 5 min. Next, the sections were pre-incubated with 10% normal
donkey serum (NDS) in phosphate-buffered saline with glycine
(PBSG). First, antibodies were applied overnight (see Table 1),
after rinsing, followed by the secondary antibodies (see Table
1) for 1 h. For the double staining, the second first antibodies
were also applied overnight. Nuclear staining was performed
with DAPI. The sections were mounted with a glycerol based
mounting medium containing 1, 4-Diazobicyclo-(2,2,2-octane
(DABCO). Microscopic photographs of the immunofluorescence
stained sections were taken.
Immunohistochemical Staining of Palatal
CXCL12 Expression
Paraffin-embedded coronal palatal sections from the wt E15 and
HO-2 KO E15 fetuses, containing a full or partial MES, were
selected. Endogenous peroxidase activity was quenched with 3%
H2O2 in methanol for 20 min. No antigen retrieval was used.
Next, the sections were pre-incubated with 10% NDS in PBSG.
First antibody for CXCL12 (see Table 1) was diluted in 2% NDS
in PBSG and incubated overnight at 4◦C. After washing with
PBSG, sections were incubated for 60 min with a biotin-labeled
second antibody against host species (see Table 1) as previously
described (Tan et al., 2009). Next, the sections were washed with
PBSG and treated with avidin-biotin peroxidase complex (ABC)
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FIGURE 4 | MES disintegration despite HO-2 abrogation and palatal fusion despite HO-activity inhibition from E11. In the HE-stained coronal palatal sections of the
wt E15 and HO-2 KO E15 fetuses, the palatal shelves were attached and disintegration of the MES was found. In the HE-stained coronal palatal sections from wt
CD1 E16 and wt CD1 SnMP E16 fetuses, the palatal shelves were fused. Representative palatal section per group was shown.
for 45 min in the dark. After extensive washing with PBSG,
diaminobenzidine-peroxidase (DAB) staining was performed for
10 min for the CXCL12 staining. Finally, the nuclei were stained
with Hematoxylin for 10 s and sections were rinsed for 10 min
in water, dehydrated, and embedded in distyrene plasticizer
xylene (DPX). Microscopic photographs of the CXCL12 stained
sections were taken.
Quantification of CXCL12
Immunoreactivity in the Palatal
Epithelium
The CXCL12 immunostained coronal palatal sections from
the wt E15 and HO-2 KO E15 fetuses were examined.
Within each section the epithelium of the palatal shelves
was subdivided into three separate regions of interest (Inside,
Outside, and Lateral nasal wall) according to morphological
characteristics (epithelium region classification) as previously
described (Suttorp et al., 2017). The epithelial regions per
single section were semi-quantitatively scored according to
the immunoreactivity scoring scale in three categories: HIGH,
MODERATE and LOW (for details see Figure 2). CXCL12
immunoreactivity was evaluated by two observers, independently
and blinded for the groups. The inter- and intra-examiner
reliability was determined. For each individual fetus the modus
of the scoring per epithelial region was calculated.
Quantification of CXCL12-Positive Cells
in the Palatal Mesenchyme
Because the coronal palatal sections showed a significant variance
in size of the palatal shelves, CXCL12 staining was adjusted
to the surface area. The individual cross-sectional surface of
the inner and outer half of each pair of shelves was measured
using Fiji Image J 1.51n software (Zeiss, Göttingen, Germany).
Then, the number of CXCL12-positive cells within the outline
of the inner and outer half of the mesenchyme of the palatal
shelves was counted (for details see Figure 3). The number of
mesenchymal CXCL12-positive cells/mm2 per inner and outer
half of the palatal mesenchyme per section was calculated. Cell
counting was performed by two observers, independently and
blinded for the groups. The inter- and intra-examiner reliability
was determined. For each individual fetus the mean number of
mesenchymal CXCL12-positive cells/mm2 per inner and outer
half of the mesenchyme of the palatal shelves was calculated.
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FIGURE 5 | Palatal osteogenesis during MES disintegration: (A) Upper panel: Histochemical stained coronal palatal section for ALP-activity, representative for the wt
E15 and HO-2 KO E15 fetuses. Middle panel: Magnification of the central part of the fusing palate including the MES. The palatal mesenchymal cells demonstrated
positive staining for ALP-activity. Green panel: Magnification of the nasal septum. A cluster of ALP-activity positive-stained mesenchymal cells was found in the
region lateral from the nasal septum including some small bone matrix depositions (red arrow). Red panel: Magnification of the lateral part of the palatal shelve.
A cluster of ALP-positive stained mesenchymal cells was found including small bone matrix depositions (red arrow). (B) Upper panel: Histochemical stained sections
through the maxilla for ALP-activity, representative for the wt CD1 E16 and wt CD1 SnMP E16 fetuses. Middle panel: Magnification of the central part of the fusing
palate. A cluster of ALP-positive stained mesenchymal cells including bone matrix depositions was found at the former location of the MES and was regarded as an
osteogenic center. Green panel: Magnification of the nasal septum. A cluster of ALP-positive-stained mesenchymal cells surrounding a large area of bone matrix
deposition (red arrow) was found. Red panel: Magnification of the lateral part of the palatal shelve. A cluster of ALP-positive-stained mesenchymal cells in the lateral
part of the fusing palate surrounding a large area of bone matrix deposition (red arrow) was found.
FIGURE 6 | Sox9 expressing cells in the MES and the palatal osteogenic centers. Upper panels: Fluorescent immunohistochemical-stained coronal palatal sections
for Sox9-activity (red), representative for the wt E15 fetuses and HO-2 KO E15 fetuses. Middle panels: Strong Sox9 expressing cells (red) were found in the remnants
of the MES. Green panels: Sox9 expressing mesenchymal cells were present in the osteogenic centers at the oral side of the forming nasal septum, and also in the
cartilage of the nasal septum. Red panels: The osteogenic centers in the lateral parts of the fusing palate demonstrated clusters of strong Sox9 expressing cells.
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FIGURE 7 | CXCR4 expressing cells in the palatal osteogenic centers. (A) Upper panel: Fluorescent immunohistochemical-stained coronal palatal section for CXCR4
expression (green), representative for the wt E15 and HO-2 KO E15, e.g., HO-2 KO. Middle panel: Within the disintegrating MES almost no CXCR4 expressing cells
were found. Green panel: Near the forming nasal septum clusters of strong CXCR4 expressing cells were found. Also within the cartilage of the forming nasal
septum CXCR4 expressing cells were present. Red panel: The osteogenic centers in the lateral parts of the fusing palate demonstrated clusters of strong CXCR4
expressing cells. (B) Upper panel: Fluorescent immunohistochemical stained coronal palatal section for CXCR4 expression (green), representative for the wt CD1
E16 and wt CD1 SnMP E16 fetuses, e.g., wt CD1 SnMP E16. Middle panel: in the osteogenic centers in the central part of the fusing palate clusters of
CXCR4-positive-stained mesenchymal cells were found. Green panel: Near the forming nasal septum clusters of strong CXCR4 expressing cells were found. Also
within the cartilage of the forming nasal septum CXCR4 expressing cells were present. Red panel: The osteogenic centers in the lateral parts of the fusing palate
demonstrated clusters of strong CXCR4 expressing cells.
Statistical Analysis
The fetal loss rate of the wt E15 and HO-2 KO E15 fetuses,
and the wt CD1 E16 and wt CD1 SnMP E16 fetuses, showed
a non-normal distribution as evaluated by the Kolmogorov-
Smirnov test (KS-test). The differences in fetal loss rate between
those groups were compared using the non-parametric Kruskal-
Wallis ANOVA on ranks test and Dunn’s Multiple Comparison
post hoc test.
The fetal body weight of the wt E15 and HO-2 KO E15
fetuses showed a normal distribution as evaluated by the KS-test.
To compare differences between those groups the Independent-
Samples T-test was performed. The fetal body weight of the
wt CD1 E16 and wt CD1 SnMP E16 fetuses showed a non-
normal distribution as evaluated by the KS-test. The non-
parametric Mann-Whitney test was used to compare differences
between both groups.
The CXCL12 immunoreactivity in the three regions of interest
of the palatal epithelium of the wt E15 and HO-2 KO E15 fetuses
was semi-quantitatively scored and analyzed using the non-
parametric Kruskal-Wallis ANOVA on ranks test and Dunn’s
Multiple Comparison post hoc test to compare differences
between both groups.
The number of CXCL12-positive cells/mm2 within the outline
of the inner and outer half of the palatal mesenchyme of
the wt E15 and HO-2 KO E15 fetuses was quantitatively
scored and showed a normal distribution as evaluated by
the KS-test. The data was analyzed using the ANOVA
and Tukey’s multiple comparison post hoc test to compare
differences between the inner and outer half of the palatal
mesenchyme of both groups.
To determine the inter- and intra-examiner reliability for the
semi-quantitative data of the CXCL12 immunoreactivity
in the epithelium, the Cohen’s kappa coefficient was
calculated. Acceptable scores >0.80 were obtained for the
semi-quantitatively scoring.
To determine the inter- and intra-examiner reliability, the
coefficient of determination (R2) was calculated by the square
of the Pearson correlation coefficient for the quantitative data
of the CXCL12-positive cells/mm2 in the palatal mesenchyme.
Acceptable scores >0.80 were obtained for the counting.
Differences were considered to be significant if p < 0.05.
All statistical analyses were performed using Graphpad
Prism 5.03 software (GraphPad Software, San Diego,
CA, United States).
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FIGURE 8 | Most CXCR4-positive cells in the palatal osteogenic centers are not positive for Sox9. (A) Upper panel: Fluorescent immunohistochemical
double-stained coronal palatal section for Sox9 (red) with CXCR4 (green), representative for the wt E15 and HO-2 KO E15 fetuses. Middle panel: Near the
disintegrating MES only a few Sox9-CXCR4 double-positive stained cells (white arrow) were found. Green panel: In the osteogenic centers near the forming nasal
septum clusters of Sox9 expressing cells together with CXCR4 expressing cells. Red panel: The osteogenic centers in the lateral parts of the fusing palate
demonstrated clusters of Sox9 expressing cells near CXCR4 expressing cells. (B) Upper panel: Fluorescent histochemical double-stained coronal palatal section for
Sox9 (red) with CXCR4 (green), representative for the wt CD1 E16 and wt CD1 SnMP E16 fetuses, e.g., wt CD1 SnMP E16. Middle panel: In the osteogenic centers
in the central part of the fusing palate, almost no Sox9-CXCR4 double-positive stained cells were found. Green panel: Near the forming nasal septum clusters of
CXCR4 expressing cells were found near CXCR4 positive cells. Also in the cartilage of the nasal septum CXCR4 positive cells were found close to Sox9 positive
cells. Red panel: The osteogenic centers in the lateral parts of the fusing palate demonstrated clusters of Sox9 expressing cells near CXCR4 expressing cells.
RESULTS
MES Disintegration Despite HO-2
Abrogation and Palatal Fusion Despite
HO-Activity Inhibition From E11
In the HE-stained coronal palatal sections of the wt E15 and
HO-2 KO E15 fetuses, the tips of the palatal shelves were attached
and disintegration of the MES was found. In the HE-stained
sections from the wt CD1 E16 and wt CD1 SnMP E16 fetuses,
the palatal shelves were fused. Representative palatal section per
group was shown in Figure 4.
Palatal Osteogenesis During MES
Disintegration Is Normal Despite
HO-Activity Inhibition
In the coronal palatal sections of the wt E15 and HO-2 KO
E15 fetuses, clusters of ALP-positive-stained mesenchymal cells
including small bone matrix depositions were found in the
regions lateral of the fusing palatal shelves and lateral near
the nasal septum. No disruption of ALP expression due to
HO-2 abrogation was found. In the coronal palatal sections
of the wt CD1 E16 and wt CD1 SnMP E16 fetuses, clusters
of ALP-positive-stained mesenchymal cells surrounding large
areas of bone depositions were found in both the center and
lateral regions of the palatal shelves, and lateral near the
nasal septum. Because of their ALP-activity, and their location
around bone depositions, these ALP-positive clustered cells
were regarded as osteoblast progenitors and osteoblasts. No
disruption of ALP activity due to HO-activity inhibition was
found. Representative section per group are shown in Figure 5.
The clusters of ALP-positive-stained mesenchymal cells of the
fusing palate were considered as palatal osteogenic centers and
determined as region of interest for studying CXCL12, CXCR4,
and Sox9 expression.
Sox9 Expressing Cells Present in the
MES and Palatal Osteogenic Centers
In both wt E15 and HO-2 KO E15 fetuses, Sox9 high-
expressing cells were found in the disintegrating MES. Moreover,
clusters of Sox9-positive mesenchymal cells were found in the
osteogenic centers in the lateral parts of the fusing palate and
at the oral side of the forming nasal septum. Regarding their
clustered arrangement in the osteogenic centers it was assumed
that these Sox9-positive cells are predominantly osteoblast
progenitors. Furthermore, Sox9 expressing mesenchymal cells
were present in the cartilage of the nasal septum, and are
likely chondroblasts because of their specific position (see
Figure 6). The non-specific autofluorescence is shown in
Supplementary Figure 1A.
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FIGURE 9 | HO-1 expressing cells in the palatal osteogenic centers. (A) Upper panel: Fluorescent histochemical stained coronal palatal section for HO-1 expression
(green), representative for the wt E15 and HO-2 KO E15 fetuses, e.g., HO-2 KO E15. Middle panel: In the mesenchyme near the disintegrating MES some HO-1
expressing cells (white arrow) were found. Green panel: Near the forming nasal septum clusters of strong HO-1 expressing cells were found. Red panel: The
osteogenic centers in the lateral parts of the fusing palate demonstrated clusters of strong HO-1 expressing cells. (B) Upper panel: Fluorescent
histochemical-stained coronal palatal section for HO-1 expression (green), representative for the wt CD1 E16 and wt CD1 SnMP E16 fetuses. Middle panel: In the
central part of the fusing palate some HO-1 expressing cells were found. Green panel: Near the forming nasal septum clusters of strong HO-1 expressing cells were
found. Red panel: The osteogenic centers in the lateral parts of the fusing palate demonstrated clusters of strong HO-1 expressing cells.
CXCR4 Expressing Cells in the Palatal
Osteogenic Centers
In both wt E15 and HO-2 KO E15 fetuses, clusters of CXCR4-
positive mesenchymal cells were found in the osteogenic
centers in the lateral parts of the fusing palate. No CXCR4
expression was found within the disintegrating MES. In the
wt CD1 E16 and wt CD1 SnMP E16 fetuses, CXCR4-
positive stained cells in the osteogenic centers in both the
central and lateral parts of the forming palate were found.
Furthermore, at the oral side of the forming nasal septum
CXCR4 expressing cells were found at E15 and E16 (see
Figure 7). Regarding their clustered arrangement in the
osteogenic centers, these CXCR4-positive mesenchymal cells
were supposed to be primarily osteoblasts. In the cartilage
of the nasal septum, the observed CXCR4-positive cells were
considered to be generally chondroblasts. The non-specific
staining of the second antibody for CXCR4 is shown in
Supplementary Figure 1B.
Most CXCR4-Positive Cells in the Palatal
Osteogenic Centers Are Not Positive for
Sox9
In both wt and HO-2 KO E15 fetuses, clusters of Sox9 expressing
cells surrounding CXCR4-positive cells in the osteogenic centers
in the lateral parts of the forming palate were found (see
Figure 8). Only a few Sox9-CXCR4 double-positive stained cells
were found near the remnants of the MES. In the wt CD1 E16
and wt CD1 SnMP E16 fetuses, almost no Sox9-CXCR4 double-
positive stained cells were found in the osteogenic centers in the
central part of the forming palate. In general, less Sox9 expressing
cells were found in the palatal mesenchyme in the wt CD1 E16
and wt CD1 SnMP E16 fetuses compared to the wt E15 and
HO-2 KO E15 fetuses. In the osteogenic centers, Sox9 expressing
cells were surrounding CXCR4-positive cells. At the oral side
of the forming nasal septum CXCR4 expressing cells near Sox9
expressing cells were found at E15 and E16. The observation
that Sox9-positive cells were located close to CXCR4-positive
cells surrounding the osteogenic centers supports the suggestion
that these Sox9-positive cells could be osteoblast progenitors to
maintain the osteoblast pool to drive osteogenesis.
HO-1 Expressing Cells in the Palatal
Osteogenic Centers
In both wt E15 and HO-2 KO E15 fetuses, HO-1-positive-stained
cells were found in the osteogenic centers in the central part
but mainly in the osteogenic centers in the lateral parts of the
forming palate. In the wt CD1 E16 and wt CD1 SnMP E16
fetuses, a few HO-1-positive stained cells were found in the
osteogenic centers in the central part, but clusters of HO-1-
positive stained cells were dominantly found in the osteogenic
centers in the lateral parts of the forming palate. At the oral side
of the forming nasal septum, HO-1 expressing cells were found
at E15 and E16 (see Figure 9). Since many HO-1-positive cells
were found in the osteogenic centers, they were considered to be
predominantly osteoblasts.
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FIGURE 10 | Most HO-1 positive cells in the palatal osteogenic centers are not positive for Sox9. (A) Upper panel: Fluorescent histochemical double-stained coronal
palatal section for Sox9 (red) with HO-1 (green), representative for the wt E15 and HO-2 KO E15 fetuses, e.g., HO-2 KO E15. Middle panel: Near the disintegrating
MES Sox9-HO-1 double-positive-stained cells (white arrow) were sporadically found. Green panel: In the osteogenic centers near the forming nasal septum clusters
some HO-1 expressing cells were found. Furthermore, some solitary HO-1 expressing cells (yellow arrow) were found. In the cartilage of the nasal septum, multiple
Sox9 expressing cells were found. Red panel: The osteogenic centers in the lateral parts of the fusing palate demonstrated clusters of HO-1 expressing cells, and
solitary strong HO-1 expressing cells (yellow arrows) in the mesenchyme. (B) Upper panel: Fluorescent histochemical double-stained coronal palatal section for Sox9
(red) with HO-1 (green), representative for the wt CD1 E16 and wt CD1 SnMP E16 fetuses. Middle panel: In the fusing palate clusters of HO-1, expressing cells were
found within the palatal osteogenic centers. Green panel: Near the forming nasal septum clusters of HO-1 expressing cells were found. In the cartilage of the nasal
septum multiple Sox9 expressing cells were found. Red panel: The osteogenic centers in the lateral parts of the fusing palate demonstrated clusters of HO-1
expressing cells.
Most HO-1-Positive Cells in the Palatal
Osteogenic Centers Are Not Positive for
Sox9
In both wt and HO-2 KO E15 fetuses, only a few Sox9-
HO-1 double-positive stained cells were found near the
remnants of the MES (see Figure 10). In the wt CD1 E16
and wt CD1 SnMP E16 fetuses, HO-1 expressing cells were
found in the osteogenic centers in the central part of the
forming palate, but almost no Sox9-HO-1 double-positive
stained cells were found. At the oral side of the forming
nasal septum, clusters of HO-1 expressing cells were present
(see Figure 10). The examination that Sox9-positive cells
surrounded the osteogenic centers containing multiple HO-1-
positive cells possibly means that osteoblast progenitors are
not HO-1 positive.
CXCL12 Expression Present in the MES
and Palatal Osteogenic Centers
Chemokine CXCL12 was significantly higher expressed in the
inside epithelial region including the MES (Inside) of the wt
E15 and HO-2 KO E15 fetuses compared to the other epithelial
layers of the fusing palatal shelves (Outside), and the lateral
epithelium of the nasal cavity (Lateral nasal wall) (p < 0.001) (see
Figures 11A,B).
CXCL12 expressing cells were also observed in the
mesenchyme of the palatal shelves, but the number of CXCL12-
positive cells/mm2 in palatal section showed no significant
difference between the wt E15 and HO-2 KO E15 fetuses,
and between the inner half and outer half (p = 0.85) (see
Figure 11C). Based on their uniformly distribution, a majority
of these CXCL12-positive cells in the palatal mesenchymal
were considered to be fibroblasts. Furthermore, the osteogenic
centers in the lateral parts of the fusing palate demonstrated
clusters of strong CXCL12 expressing cells. Considering their
clustered arrangement in the osteogenic centers, these CXCL12-
positive cells were thought to be osteoblast progenitors or
osteoblasts. Also within the cartilage of the forming nasal septum
CXCL12 expressing cells were present, and these cells were
regarded as chondroblast because of their specific location (see
Figure 11A).
Fetal Resorption Independent of HO-2
Expression and HO-Activity
Approximately half of the wt E15 and HO-2 KO E15 fetuses were
resorbed. Contrarily, in the wt CD1 E16 and wt CD1 SnMP E16
fetuses, the number of fetal resorptions was low (less than 7%).
Higher fetal loss rate was found in the HO-2 KO E15 group
compared to both the wt CD1 E16 and wt CD1 SnMP groups
(p < 0.05) (see Figure 12). Disruption of HO-2 expression and
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FIGURE 11 | CXCL12 expression in the MES and palatal osteogenic centers. (A) Upper panel: Coronal palatal section stained for CXCL12 expression,
representative for the wt and HO-2 KO fetuses. Middle panel: Magnification of the central part of the fusing palate including the MES. The MES demonstrated strong
CXCL12 expression. CXCL12-positive cells were also found in the palatal mesenchyme. Green panel: The osteogenic centers at the lateral/oral side of the nasal
septum demonstrated clusters of strong CXCL12 expressing cells. Also in the cartilage of the forming nasal septum CXCL12 expressing cells were present. Red
panel: The osteogenic centers in the lateral parts of the fusing palate demonstrated clusters of strong CXCL12 expressing cells. (B) Box-and-whisker plot with
10–90 percentiles of semi-quantitative assessment of the CXCL12 expression in the palatal epithelial layers (scoring scale in three categories: 1 = HIGH,
2 = MODERATE and 3 = LOW) compared for the different regions in sections from wt E15 (n = 7) and HO-2 KO E15 fetuses (n = 10), ∗∗∗ = p < 0.001. (C) Bar chart
of the number of mesenchymal CXCL12-positive cells cells/mm2 compared for the wt E15 (n = 7) and HO-2 KO E15 fetuses (n = 10) between the outline of the inner
and outer half of the mesenchyme. Data are shown as mean ± SD. No statistically significant differences in CXCL12 expression were found (p = 0.85).
HO-activity inhibition both did not result in increased fetal loss
(p > 0.05).
Fetal Body Weight Is Decreased by
Absence of HO-2 Expression but
Increased by HO-Activity Inhibition
From E11
The HO-2 KO E15 fetuses demonstrated a reduced fetal
body weight compared to the wt E15 fetuses (p = 0.0416)
(Figures 13A,B). On the other hand, in CD1 fetuses of E16,
inhibition of the HO-activity by SnMP from E11 increased the
fetal body weight (p < 0.0001) (Figures 13C,D). A representative
fetus per group is shown in Figures 13B,D.
DISCUSSION
We found clusters of Sox9 expressing cells surrounding CXCR4-
positive cells in the ALP-positive osteogenic centers of the
palatal shelves at E15 and E16 in wt mice. However, most
Sox9 positive cells in the palate were not positive for CXCR4
expression. Furthermore, we showed that chemokine CXCL12,
the ligand of receptor CXCR4, was overexpressed within these
palatal osteogenic centers. Sox9, CXCR4, and CXCL12 expressing
cells were also observed within the cartilage of developing nasal
septum, suggesting their involvement in chondrogenesis. Several
in vitro and in vivo studies on the role of CXCL12-CXCR4
signaling in relation to bone formation have been performed
(Gilbert et al., 2019). CXCL12 expression in non-differentiated
mesenchymal stem cells in bone was demonstrated, but toward
the end of osteogenic differentiation CXCL12 was downregulated
(Ito, 2011). Deletion of CXCL12 in osteoprogenitor cells resulted
in decreased bone mass in the femur bone in mice (Tzeng
et al., 2018). CXCL12 antibody administration inhibited new
bone formation during the repair of femoral bone graft in
mice (Kitaori et al., 2009). CXCR4 KO fetuses of E18.5
were smaller and showed deficient bone marrow development
compared to the controls (Ma et al., 1998). CXCR4-deficient
bone marrow-derived mesenchymal stromal stem cells from
mice exhibited impaired osteogenic differentiation in response to
BMP2 stimulation in vitro (Guang et al., 2013). Primary cultures
for osteoblastic cells derived from CXCR4 KO mice showed
decreased proliferation and impaired osteoblast differentiation
in response to BMP2 or BMP6 stimulation in vitro (Zhu
et al., 2011). Additionally, disruption of CXCR4 receptor in
mouse hematopoietic stem cells led to increased endogenous
ROS production (Zhang et al., 2016). Since our results showed
that Sox9 and CXCR4 do not have overlapping expression,
we suggest that Sox9-positive cells are osteoblast progenitors
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FIGURE 12 | Fetal resorption independent of HO-2 KO expression and HO-activity. (A) Box-and-whisker plot with 10–90 percentiles of quantitative assessment of
the fetal loss ratio in the wt (n = 3) and HO-2 KO pregnant mice (n = 4) at E15, and wt CD1 mice (n = 6) and wt CD1 SnMP mice (n = 4) at E16, ∗p < 0.05. (B) The
uteri were photographed, the green asterisk indicated a fetus, the red asterisk indicated a fetal resorption. Representative uterus per group was shown. (C) Isolated
fetus with placenta and isolated fetal resorption from the uterus.
maintaining the osteoblast pool to drive osteogenesis, and that
both CXCL12 and CXCR4 are later expressed by the mature
osteoblasts. Furthermore, we propose that Sox9 expression
and CXCL12-CXCR4 signaling in the cartilage of the nasal
septum develop chondroblast formation. Since CXCL12-CXCR4
signaling promotes osteoblast formation, it is suggesting that
CXCL12 expression by the disintegrating MES is a major initiator
of palatal osteogenesis.
Studies on CXCL12-CXCR4 signaling in the developing palate
are scarce. We provided novel evidence that chemokine CXCL12,
the ligand of receptor CXCR4, was overexpressed by the epithelial
cells of the MES, possibly to activate osteoblasts progenitors
to facilitate palatal bone formation. In human palatal sections,
CXCR4 expression was observed within the MES (Jakobsen et al.,
2009). On the contrary, in our study we did not observe CXCR4
overexpression within the disintegrating MES. We could not find
other studies that demonstrated CXCR4 expression in the MES. It
is suggesting that CXCL12 expression by the disintegrating MES
is a major initiator of palatal osteogenesis. Besides chemokine
CXCL12, the disintegrating MES demonstrated strong expression
of Sox9. Although Sox9 expression is demonstrated in the
developing palatal shelves in mice fetuses (Potter and Potter,
2015; Watanabe et al., 2016; Xu et al., 2018), to our knowledge
we are the first who demonstrated Sox9 expression specifically
in the disintegrating MES. Sox9 signaling showed to be essential
in the EMT mechanism in non-small-cell lung carcinoma
cell (Zhang et al., 2017; Huang et al., 2019), mouse embryonic
mammary cells (Kogata et al., 2018), mouse gastric cancer
cells (Li et al., 2018), human colorectal cancer cells (Choi et al.,
2017), human hepatocellular carcinoma cells (Kawai et al., 2016),
thyroid cancer cells (Huang and Guo, 2017), and avian neural
crest cells (Sakai et al., 2006) in vitro. Therefore, it’s tempting
to speculate that Sox9 expression near the MES is involved in
EMT processes, turning the basal epithelial layer of the MES into
mesenchyme during palatal fusion.
Our novel hypothetical model (Figure 14) proposes that
CXCL12-CXCR4 signaling facilitates osteogenesis during palatal
fusion in mice. Expression of Sox9 in osteoblast progenitors
was thought to initiate osteogenic differentiation by promoting
CXCL12-CXCR4 signaling. CXCL12 expression by the MES
and osteogenic centers in the fusing palatal shelves could
promote maturation of immature CXCR4-positive osteoblasts.
Sox9 progenitors thus seem important to maintain the CXCR4-
positive osteoblast pool to drive osteogenesis. Furthermore, Sox9
expression found in the MES may in addition regulate MES
disintegration by the process of EMT.
Only a few Sox9-positive cells in the palatal mesenchyme
were also positive for HO-1. Studies on the role of HO-
activity on embryonic craniofacial development in mice are
limited (Suttorp et al., 2017). As far as we know, this is the
first study on the effects of inhibition of HO-1 and HO-2 by
SnMP administration during palatogenesis. Adult HO-1 KO mice
demonstrate growth retardation (Suliman et al., 2017), but HO-2
KO mice were found to be morphologically indistinguishable
Frontiers in Cell and Developmental Biology | www.frontiersin.org 15 August 2020 | Volume 8 | Article 771
fcell-08-00771 August 19, 2020 Time: 20:17 # 16
Verheijen et al. CXCL12-CXCR4 Interplay Facilitates Palatal Osteogenesis
FIGURE 13 | Fetal body weight decreases by disruption of HO-2, but increases by HO-activity inhibition from E11. (A) Bar chart of the fetal body weight of the wt
E15 fetuses (n = 15) and HO-2 KO E15 fetuses (n = 4), ∗p < 0.05. Data are shown as mean ± SD. (B) Representative fetus per group was shown (centimeter ruler).
(C) Box-and-whisker plot with 10–90 percentiles of quantitative assessment of the body weight of the wt CD1 E16 fetuses (n = 91) and wt CD1 SnMP E16 fetuses
(n = 56), ∗∗∗p < 0.001. (D) Representative fetus per group was shown (centimeter ruler).
FIGURE 14 | Hypothetical model: CXCL12-CXCR4 interplay facilitates palatal osteogenesis. We propose that the CXCL12-CXCR4 interplay facilitates osteogenesis
during palatal fusion in mice. Expression of transcription factor Sox9 in osteoblast progenitors was thought to initiate differentiation into osteoblasts by promoting
CXCL12-CXCR4 signaling. CXCL12 expression in the midline epithelial seam could promote maturation of immature CXCR4-positive osteoblast. Sox9 progenitors
maintain the CXCR4-positive osteoblast pool to drive osteogenesis. Furthermore, Sox9 expression found in the MES, possibly regulates MES disintegration by the
process of epithelial-to-mesenchymal transformation (EMT).
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from wt mice (Poss et al., 1995). In rat, HO-1 inhibition by
zinc deuteroporphyrin IX 2,4 bis glycol resulted in a significant
decrease in pup size (Kreiser et al., 2002). This study showed that
neither adhesion of the palatal shelves nor Sox9 and CXCL12
expression by the MES was affected by HO-2 KO disruption. We
found that pharmacologically blocking of HO-activity by SnMP
did not disturb palatal fusion or expression of Sox9, CXCR4,
HO-1, and ALP-activity in the osteogenic regions.
Besides the absence of HO-activity, we did not further
disturb the pregnancy by additional oxidative and inflammatory
stress. Interestingly, HO-1 expression, but not HO-2, was
found to rescue mesenchymal stem cells from H2O2-induced
cell death in vitro (Cremers et al., 2014). It is likely that
the role of HO is underestimated when its function is
studied only during normal physiological conditions. For future
experiments we consider to combine HO-activity inhibition
with heme administration in different dose to study the effects
of higher oxidative and inflammatory stress levels at palatal
fusion. More research is needed to elucidate the relation
between HO-activity and palatogenesis during stress-induced
pathological pregnancy.
In our study, HO-2 abrogation demonstrated no increased
fetal loss since both the HO-2 KO mice and wt mice showed
a high fetal loss rate. Others found that HO-2 KO mice were
fertile (Poss et al., 1995; Lundvig et al., 2014), although, no
information was provided about the litter size. In another
study, an increased abortion rate in mice was experimentally
generated by lipopolysaccharide (LPS) injection at E18 in a dose-
dependent fashion (Toyama et al., 2015). A limitation of the
present study was the relatively small number of wt E15 and
HO-2 KO E15 fetuses. Although we tried to enhance the fertility
by administration of the hormones Folligonan and Pregnyl
before mating, only three out of seven plugged wt mice, and
four out of seven plugged HO-2 KO mice carried fetuses. It
is suggested that the low fertility and high fetal loss rate in
our mice with mixed 129Sv × C57BL/6 background possibly
have dominated the effects of HO-2 abrogation in this study.
However, our data could not provide evidence for this statement.
The low fertility could possibly be explained by the excessive
inbreeding within the colony. For future studies this problem
could be solved by breeding homozygous HO-2 knockouts with
hybrid 129Sv × C57BL/6 wt mice. By breeding the resulting
heterozygotes, wt and homozygous HO-2 KO mice would then
be obtained. HO-activity inhibition from E11 was not found
to increase the fetal loss rate compared to the controls. HO-
activity inhibition by administration of zinc mesoporphyrin
early in pregnancy in mice between E0-E6 was also found to
increase the abortion rate (Sollwedel et al., 2005; Schumacher
et al., 2012). We demonstrated that HO-2 KO fetuses showed
a reduced fetal body weight, but, interestingly, pharmacological
blocking of HO-activity by SnMP administration at E11 resulted
into a higher fetal body weight. This suggests that during
implantation HO-activity promotes fetal growth, whereas HO-
activity at later moments (E11–E16) inhibits embryonal growth.
In fact, others showed that adult HO-2 KO mice were obese,
induced by disrupted metabolic homeostasis, caused by insulin
resistance and elevated blood pressure (Cao et al., 2012). It would
then be interesting to investigate whether induction of HO-1
could indeed counteract this obesity. However, no difference
in phenotype was found between HO-2 KO and wt mice by
others (Qu et al., 2005). We hypothesize that HO-activity is
especially essential during implantation and early embryonic
development, but stress-level-dependent in the later stages of
fetal development.
In conclusion, our results support the hypothesis that
CXCL12-CXCR4 interplay facilitates palatal osteogenesis during
palatal fusion in mice. To the best of our knowledge, this is
the first study demonstrating Sox9 and CXCL12 expression in
the disintegrating MES and other palatal osteogenic centers.
Neither CXCL12 expression during the MES disintegration nor
palatal fusion was affected by HO-2 abrogation or inhibition of
HO-activity. Further research is needed to unravel the role of
cytoprotective HO-activity in the presence of additional oxidative
and inflammatory stresses in relation to the development of
craniofacial malformations, including palatal clefting.
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